PALI – palisade bio, inc. (US:NASDAQ)

News

Palisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models [Yahoo! Finance]
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Palisade Bio Appoints Margery Fischbein to its Board of Directors [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com